These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32865902)

  • 1. Combination Cancer Therapy Using Multifunctional Liposomes.
    Jain A; Tiwari A; Verma A; Saraf S; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(2):105-134. PubMed ID: 32865902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
    Tavano L; Muzzalupo R
    Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Long-Circulating and Fusogenic Liposomes Co-encapsulating Paclitaxel and Doxorubicin in Synergistic Ratio for the Treatment of Breast Cancer.
    Roque MC; Franco MS; Vilela JMC; Andrade MS; de Barros ALB; Leite EA; Oliveira MC
    Curr Drug Deliv; 2019; 16(9):829-838. PubMed ID: 31622204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.
    Rui M; Xin Y; Li R; Ge Y; Feng C; Xu X
    Mol Pharm; 2017 Jan; 14(1):107-123. PubMed ID: 27982602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent.
    Liu J; Chi D; Pan S; Zhao L; Wang X; Wang D; Wang Y
    Int J Pharm; 2019 Feb; 557():264-272. PubMed ID: 30599233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.
    Su CW; Chiang CS; Li WM; Hu SH; Chen SY
    Nanomedicine (Lond); 2014 Jul; 9(10):1499-515. PubMed ID: 25253498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes Co- encapsulating Anticancer Drugs in Synergistic Ratios as an Approach to Promote Increased Efficacy and Greater Safety.
    Franco MS; Oliveira MC
    Anticancer Agents Med Chem; 2019; 19(1):17-28. PubMed ID: 29692263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated Nanoliposomes Potentiated Oral Combination Therapy for Effective Cancer Treatment.
    Singh A; Neupane YR; Mangla B; Shafi S; Kohli K
    Curr Drug Deliv; 2020; 17(9):728-735. PubMed ID: 32713341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Application of Liposomes as Drug Delivery Systems for the Diagnosis and Treatment of Cancer.
    Allahou LW; Madani SY; Seifalian A
    Int J Biomater; 2021; 2021():3041969. PubMed ID: 34512761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a biodegradable, versatile nanocarrier for optional combination cancer therapy.
    Wen J; Lv Y; Xu Y; Zhang P; Li H; Chen X; Li X; Zhang L; Liu F; Zeng W; Sun S
    Acta Biomater; 2019 Jan; 83():359-371. PubMed ID: 30414486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
    Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
    Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.